Crescent Biopharma, Inc. is in its Moon mahadasha (5 Nov 2022 to 5 Nov 2032), Jupiter antardasha (6 Oct 2025 to 5 Feb 2027) and Moon pratyantar (16 Sep 2026 to 26 Oct 2026).
Next: pratyantar Mars from 26 Oct 2026; antardasha Saturn from 5 Feb 2027; mahadasha Mars from 5 Nov 2032.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Dhanu (Sagittarius) | 26°14′ | 11th | Purva Ashadha 4 |
| Moon | Mesha (Aries) | 24°47′ | 3rd | Bharani 4 |
| Mars | Kanya (Virgo) | 21°41′ | 8th | Hasta 4 |
| Mercury | Makara (Capricorn) | 3°48′ | 12th | Uttara Ashadha 3 |
| Jupiter (R) | Mithuna (Gemini) | 20°47′ | 5th | Punarvasu 1 |
| Venus (R) | Dhanu (Sagittarius) | 27°43′ | 11th | Uttara Ashadha 1 |
| Saturn | Tula (Libra) | 27°08′ | 9th | Vishakha 3 |
| Rahu | Tula (Libra) | 9°43′ | 9th | Swati 1 |
| Ketu | Mesha (Aries) | 9°43′ | 3rd | Ashwini 3 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how CBIO moved in each period against the S&P 500, transits, fundamentals and news.